Ascentage Pharma’s $126.4 Million Initial Public Offering and Nasdaq Listing

Wilson Sonsini Goodrich & Rosati acted as U.S. and Hong Kong counsel to Ascentage Pharma on the offering, and Davis Polk & Wardwell advised the underwriters.Ascentage…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Leila Ahmed

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here